ALEXANDRIA, Va., Feb. 17 -- United States Patent no. 12,552,875, issued on Feb. 17, was assigned to GSP ENTERPRISE INC. (Osaka, Japan), TOMOIKE BIO LTD. (Hong Kong) and A BIOTECH Co. LTD. (Seoul, South Korea).
"Anti-human Cripto-1 antibody" was invented by Masaharu Seno (Okayama, Japan), Atsushi Takayanagi (Osaka, Japan) and Sekyoung Lee (Seoul, South Korea).
According to the abstract* released by the U.S. Patent & Trademark Office: "An object of the present invention is to develop a technique of reducing cancer stem cells. The solution is to provide a human-derived anti-human Cripto-1 antibody containing specific amino acid sequences."
The patent was filed on Nov. 10, 2020, under Application No. 17/775,706.
*For further information, in...